RxDoctor Payments Data

Aaron Waite, MD

Ophthalmology · Lehi, UTNPI 1285759548

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,150 of the $11,535 with a category attached, or 70.7%. Lensar, Inc. accounts for 94.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $11,028 and has fallen 99.0% since, to $111 in 2025. Among ophthalmology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,535in general payments, 2019–2025

Across 27 payments — averaging $427.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lensar, Inc.$11K
  • Johnson & Johnson Surgical Vision, Inc.$186
  • Rxsight Inc$167
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$159
  • AbbVie$48
  • Sight Sciences, Inc.$18
  • plus $28 from 2 others

What the payments were for

  • Consulting fees$8,15071%
  • Speaking & faculty fees$2,53222%
  • Food & beverage$8527%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,535 in reported general payments places this provider in the 90th percentile of 191 ophthalmology providers in Utah.

See all ophthalmology providers in Utah

Medicare billing

Part B allowed, 2024
$78,691
Medicare patients
108
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate12$375
Timolol Maleate11$82

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Lehi

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →